123O Randomized phase II trial of neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in early HER2-positive breast cancer (ABCSG-52/ATHENE)Gabriel Rinnerthaler, Richard Greil, Andreas Petzer et al.|ESMO Open|2023Cited by 2
Androgen receptor expression in breast cancer brain metastasesElisabeth Bergen, Rupert Bartsch, Anna S. Berghoff et al.|Annals of Oncology|2018Cited by 0